M. Furkan Burak

Brigham and Women's Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index446citations22works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peroxisome Proliferator-Activated Receptors(6), Adipokines, Inflammation, and Metabolic Diseases(5), Adipose Tissue and Metabolism(4), Diet and metabolism studies(3), Asthma and respiratory diseases(2)

Publications22 total

LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY
Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi·2025· 1 citedOpen Access
Paradigm shift in obesity treatment: an extensive review of current pipeline agents
TURKISH JOURNAL OF MEDICAL SCIENCES·2025· 3 citedOpen Access
FABP4 as a therapeutic host target controlling SARS-CoV-2 infection
EMBO Molecular Medicine·2025· 4 citedOpen Access
An adipo-pulmonary axis mediated by FABP4 hormone defines a target against obesity-induced airway disease
2024
Serum fatty-acid binding protein is associated with lung function in asthma
2024
Clinical Unmet Needs in Hypoparathyroidism and Current Pipeline Agents
Endocrinology research and practice.·2024Open Access
An Adipo-Pulmonary Axis Mediated by FABP4 Hormone Defines a Therapeutic Target Against Obesity-Induced Airway Disease
2024Open Access
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023
American Journal of Clinical Nutrition·2024· 12 citedOpen Access
From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology
Journal of the Endocrine Society·2024Open Access
FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection
2024· 1 citedOpen Access
Protocol for a randomized placebo-controlled clinical trial using pure palmitoleic acid to ameliorate insulin resistance and lipogenesis in overweight and obese subjects with prediabetes
Frontiers in Endocrinology·2024· 9 citedOpen Access
Mechanisms of Drug Action in Obesity
2023
Endothelial-derived FABP4 constitutes the majority of basal circulating hormone and regulates lipolysis-driven insulin secretion
JCI Insight·2023· 17 citedOpen Access
Short-Term Pre-Operative Protein Caloric Restriction in Elective Vascular Surgery Patients: A Randomized Clinical Trial
Nutrients·2021· 11 citedOpen Access
Abstract #787708: Identification of FABP4 (AP2) as an Adipo-Pulmonary Regulator of Airway Function in Obesity Related Asthma
Endocrine Practice·2020
Insights From a Short-Term Protein–Calorie Restriction Exploratory Trial in Elective Carotid Endarterectomy Patients
Vascular and Endovascular Surgery·2019· 15 cited
Abstract 445: Insights from a Short-term Protein-Calorie Restriction Exploratory Trial in Elective Carotid Endarterectomy Patients
Arteriosclerosis Thrombosis and Vascular Biology·2019
OR01-1 Leveraging Immunometabolic Control to Prevent and Treat Obesity Related Asthma
Journal of the Endocrine Society·2019· 1 citedOpen Access
Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2
The Journal of Clinical Endocrinology & Metabolism·2018· 10 citedOpen Access
Abstract #226 Development of an Anti-Ap2 Monoclonal Antibody to Treat Obesity Related Diabetes and Fatty Liver Disease
Endocrine Practice·2018
page 1 of 2Next →

Frequent Co-authors

Gökhan S. Hotamışlıgil(11), Gürol Tuncman(7), Karen Inouye(5), Ecesu Çetin(4), Ariel White(3), Peter Kip(3), Ming Tao(3), James J. O’Leary(3), Jack Ruske(3), Michael R. MacArthur(3), James R. Mitchell(3), C. Keith Ozaki(3), Elliot Israel(3), Motohiro Sekiya(2), Alexandra Lee(2), Kaspar Trocha(2), Jennifer M. Giulietti(2), Andrew Bolze(2), Suzannah Patterson(2), Karen J. Ho(2)